Usefulness of Pseudocontinuous Arterial Spin-Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period

References

1. 1.↵
   2. Homma A,
   3. Oridate N,
   4. Suzuki F, et al

   . Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009;115:4705–14 doi:10.1002/cncr.24515 pmid:19634162

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Wong SJ,
   3. Harari PM,
   4. Garden AS, et al

   . Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States. Cancer 2011;117:1679–86 doi:10.1002/cncr.25721 pmid:21472715

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Kimata Y,
   3. Uchiyama K,
   4. Ebihara S, et al

   . Postoperative complications and functional results after total glossectomy with microvascular reconstruction. Plast Reconstr Surg 2000;106:1028–35 doi:10.1097/00006534-200010000-00012 pmid:11039374

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Eisenhauer EA,
   3. Therasse P,
   4. Bogaerts J, et al

   . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47 doi:10.1016/j.ejca.2008.10.026 pmid:19097774

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Cao Y,
   3. Popovtzer A,
   4. Li D, et al

   . Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008;72:1287–90 doi:10.1016/j.ijrobp.2008.08.024 pmid:19028268

   CrossRefPubMed
6. 6.↵
   2. Fujima N,
   3. Kudo K,
   4. Yoshida D, et al

   . Arterial spin labeling to determine tumor viability in head and neck cancer before and after treatment. J Magn Reson Imaging 2014;40:920–28 doi:10.1002/jmri.24421 pmid:25356468

   CrossRefPubMed
7. 7.↵
   2. Folkman J,
   3. Klagsbrun M

   . Angiogenic factors. Science 1987;235:442–47 doi:10.1126/science.2432664 pmid:2432664

   Abstract/FREE Full Text
8. 8.↵
   2. Faggioni L,
   3. Neri E,
   4. Bartolozzi C

   . CT perfusion of head and neck tumors: how we do it. AJR Am J Roentgenol 2010;194:62–69 doi:10.2214/AJR.09.3187 pmid:20028906

   CrossRefPubMed
9. 9.↵
   2. Li XS,
   3. Fan HX,
   4. Zhu HX, et al

   . The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer. Eur Radiol 2012;22:617–24 doi:10.1007/s00330-011-2280-6 pmid:21960157

   CrossRefPubMed
10. 10.↵
    2. Agrawal S,
    3. Awasthi R,
    4. Singh A, et al

    . An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers. Clin Radiol 2012;67:e1–5 doi:10.1016/j.crad.2012.03.005 pmid:22583950

    CrossRefPubMed
11. 11.↵
    2. Bisdas S,
    3. Medov L,
    4. Baghi M, et al

    . A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol 2008;18:843–50 doi:10.1007/s00330-007-0827-3 pmid:18175123

    CrossRefPubMed
12. 12.↵
    2. de Jongh FE,
    3. van Veen RN,
    4. Veltman SJ, et al

    . Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer 2003;88:1199–206 doi:10.1038/sj.bjc.6600884 pmid:12698184

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Daugaard G,
    3. Abildgaard U,
    4. Holstein-Rathlou NH, et al

    . Renal tubular function in patients treated with high-dose cisplatin. Clin Pharmacol Ther 1988;44:164–72 doi:10.1038/clpt.1988.132 pmid:2840230

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Truong MT,
    3. Saito N,
    4. Ozonoff A, et al

    . Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy. AJNR Am J Neuroradiol 2011;32:1195–201 doi:10.3174/ajnr.A2501 pmid:21757530

    Abstract/FREE Full Text
15. 15.↵
    2. Surlan-Popovic K,
    3. Bisdas S,
    4. Rumboldt Z, et al

    . Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010;31:570–75 doi:10.3174/ajnr.A1859 pmid:19875475

    Abstract/FREE Full Text
16. 16.↵
    2. Gandhi D,
    3. Chepeha DB,
    4. Miller T, et al

    . Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101–06 pmid:16418366

    Abstract/FREE Full Text
17. 17.↵
    2. Lanzman RS,
    3. Robson PM,
    4. Sun MR, et al

    . Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology 2012;265:799–808 doi:10.1148/radiol.12112260 pmid:23047841

    CrossRefPubMed
18. 18.↵
    2. Binnewijzend MA,
    3. Kuijer JP,
    4. Benedictus MR, et al

    . Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267:221–30 doi:10.1148/radiol.12120928 pmid:23238159

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Fujima N,
    3. Kudo K,
    4. Tsukahara A, et al

    . Measurement of tumor blood flow in head and neck squamous cell carcinoma by pseudo-continuous arterial spin labeling: comparison with dynamic contrast-enhanced MRI. J Magn Reson Imaging 2015;41:983–91 doi:10.1002/jmri.24885 pmid:24723251

    CrossRefPubMed
20. 20.↵
    2. Wang Z,
    3. Aguirre GK,
    4. Rao H, et al

    . Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 2008;26:261–69 doi:10.1016/j.mri.2007.07.003 pmid:17826940

    CrossRefPubMedWeb of Science
21. 21.↵
    2. van Osch MJ,
    3. Teeuwisse WM,
    4. van Walderveen MA, et al

    . Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med 2009;62:165–73 doi:10.1002/mrm.22002 pmid:19365865

    CrossRefPubMed
22. 22.↵
    2. Wheeler RH,
    3. Ziessman HA,
    4. Medvec BR, et al

    . Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res 1986;46:4200–04 pmid:3488122

    Abstract/FREE Full Text
23. 23.↵
    2. Srinivasan A,
    3. Mohan S,
    4. Mukherji SK

    . Biologic imaging of head and neck cancer: the present and the future. AJNR Am J Neuroradiol 2012;33:586–94 doi:10.3174/ajnr.A2535 pmid:22194364

    Abstract/FREE Full Text
24. 24.↵
    2. Bhatnagar P,
    3. Subesinghe M,
    4. Patel C, et al

    . Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer. Radiographics 2013;33:1909–29 doi:10.1148/rg.337125163 pmid:24224586

    CrossRefPubMed
25. 25.↵
    2. King AD,
    3. Chow KK,
    4. Yu KH, et al

    . Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013;266:531–38 doi:10.1148/radiol.12120167 pmid:23151830

    CrossRefPubMed
26. 26.↵
    2. Kauppinen RA

    . Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002;15:6–17 doi:10.1002/nbm.742 pmid:11840548

    CrossRefPubMed
27. 27.↵
    2. Berrak S,
    3. Chawla S,
    4. Kim S, et al

    . Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol 2011;18:1225–32 doi:10.1016/j.acra.2011.06.009 pmid:21835649

    CrossRefPubMed
28. 28.↵
    2. Zwelling LA,
    3. Kohn KW

    . Mechanism of action of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 1979;63:1439–44 pmid:387221

    PubMedWeb of Science
29. 29.↵
    2. Leek RD,
    3. Landers RJ,
    4. Harris AL, et al

    . Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999;79:991–95 doi:10.1038/sj.bjc.6690158 pmid:10070902

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Martin DF,
    3. Fischer JJ

    . Radiation sensitivity of cultured rabbit aortic endothelial cells. Int J Radiat Oncol Biol Phys 1984;10:1903–06 doi:10.1016/0360-3016(84)90270-0 pmid:6490420

    CrossRefPubMed
31. 31.↵
    2. Kojima H,
    3. Endo K,
    4. Moriyama H, et al

    . Abrogation of mitochondrial cytochrome C release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 1998;273:16647–50 doi:10.1074/jbc.273.27.16647 pmid:9642215

    Abstract/FREE Full Text
32. 32.↵
    2. Godwin AK,
    3. Meister A,
    4. O'Dwyer PJ, et al

    . High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A 1992;89:3070–74 doi:10.1073/pnas.89.7.3070 pmid:1348364

    Abstract/FREE Full Text
33. 33.↵
    2. Evans SM,
    3. Du KL,
    4. Chalian AA, et al

    . Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys 2007;69:1024–31 doi:10.1016/j.ijrobp.2007.04.067 pmid:17967299

    CrossRefPubMed
34. 34.↵
    2. Delouya G,
    3. Igidbashian L,
    4. Houle A, et al

    . ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiother Oncol 2011;101:362–68 doi:10.1016/j.radonc.2011.07.025 pmid:21885143

    CrossRefPubMed